ATOSSA THERAPEUTICS, INC. Tax Withholding Paid on Stock Awards
ATOSSA THERAPEUTICS, INC. (ATOS) reported Tax Withholding Paid on Stock Awards of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-22.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2023-03-22
- ATOSSA THERAPEUTICS, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2022-12-31 was $0.00.
- ATOSSA THERAPEUTICS, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2021-12-31 was -$1.00K.
- ATOSSA THERAPEUTICS, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2020-12-31 was -$422.00.
- ATOSSA THERAPEUTICS, INC. payment, tax withholding, share-based payment arrangement for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- ATOSSA THERAPEUTICS, INC. payment, tax withholding, share-based payment arrangement for fiscal 2021 was $573.00K, a 3992.86% increase from fiscal 2020.
- ATOSSA THERAPEUTICS, INC. payment, tax withholding, share-based payment arrangement for fiscal 2020 was $14.00K.
| Period end | Payment, Tax Withholding, Share-based Payment Arrangement 3 month | Payment, Tax Withholding, Share-based Payment Arrangement 9 month | Payment, Tax Withholding, Share-based Payment Arrangement 9 month as first filed | Payment, Tax Withholding, Share-based Payment Arrangement 12 month | Payment, Tax Withholding, Share-based Payment Arrangement 12 month as first filed |
|---|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $0.00 10-K · filed 2023-03-22 | |||
| 2022-09-30 | $0.00 10-Q · filed 2022-11-07 | ||||
| 2021-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $573.00K 10-K · filed 2023-03-22 | |||
| 2021-09-30 | $574.00K 10-Q · filed 2022-11-07 | $574.87K 10-Q · filed 2021-11-15 | |||
| 2020-12-31 | -$422.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $14.00K 10-K · filed 2022-02-28 | $14.42K 10-K · filed 2021-03-31 | ||
| 2020-09-30 | $14.42K 10-Q · filed 2021-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |